Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells.

ABSTRACT:

SUBMITTER: Fiskus W 

PROVIDER: S-EPMC8803998 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature